Published in Biochem J on February 15, 2005
Proteoglycomics: recent progress and future challenges. OMICS (2010) 1.25
Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy. Clin Cancer Res (2010) 0.97
Biochemical characterization of the chondroitinase ABC I active site. Biochem J (2005) 0.95
CS lyases: structure, activity, and applications in analysis and the treatment of diseases. Adv Pharmacol (2006) 0.93
Baculovirus envelope protein ODV-E66 is a novel chondroitinase with distinct substrate specificity. J Biol Chem (2011) 0.91
Modification of N-glycosylation sites allows secretion of bacterial chondroitinase ABC from mammalian cells. J Biotechnol (2009) 0.90
Hyaluronan and layilin mediate loss of airway epithelial barrier function induced by cigarette smoke by decreasing E-cadherin. J Biol Chem (2012) 0.90
Sialidase, chondroitinase ABC, and combination therapy after spinal cord contusion injury. J Neurotrauma (2013) 0.84
The structural elucidation of glycosaminoglycans. Methods Mol Biol (2009) 0.82
Arylsulfatase B improves locomotor function after mouse spinal cord injury. PLoS One (2013) 0.82
Differential growth factor adsorption to calvarial osteoblast-secreted extracellular matrices instructs osteoblastic behavior. PLoS One (2011) 0.81
Recombinant expression, purification, and biochemical characterization of chondroitinase ABC II from Proteus vulgaris. J Biol Chem (2008) 0.79
Chondroitin Sulfate Induces Depression of Synaptic Transmission and Modulation of Neuronal Plasticity in Rat Hippocampal Slices. Neural Plast (2015) 0.77
Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth. Mol Ther (2015) 0.75
The effect of substitution of the N-acetyl groups of N-acetylgalactosamine residues in chondroitin sulfate on its degradation by chondroitinase ABC. Glycoconj J (2007) 0.75
Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem (1999) 11.87
Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature (2002) 8.22
Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr Opin Struct Biol (2003) 2.48
Enzymatic degradation of glycosaminoglycans. Crit Rev Biochem Mol Biol (1995) 2.21
Sequencing complex polysaccharides. Science (1999) 1.85
Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res (2002) 1.70
Two distinct chondroitin sulfate ABC lyases. An endoeliminase yielding tetrasaccharides and an exoeliminase preferentially acting on oligosaccharides. J Biol Chem (1997) 1.24
Crystal structure of chondroitinase B from Flavobacterium heparinum and its complex with a disaccharide product at 1.7 A resolution. J Mol Biol (1999) 1.23
Mass spectrometric and capillary electrophoretic investigation of the enzymatic degradation of heparin-like glycosaminoglycans. Proc Natl Acad Sci U S A (1998) 1.22
Crystal structure of chondroitin AC lyase, a representative of a family of glycosaminoglycan degrading enzymes. J Mol Biol (1999) 1.19
Cloning and expression of heparinase I gene from Flavobacterium heparinum. Proc Natl Acad Sci U S A (1993) 1.14
Proteinase activity in chondroitin lyase (chondroitinase) and endo-beta-D-galactosidase (keratanase) preparations and a method to abolish their proteolytic effect on proteoglycan. Biochem J (1980) 1.14
Active site of chondroitin AC lyase revealed by the structure of enzyme-oligosaccharide complexes and mutagenesis. Biochemistry (2001) 1.08
Heparinase III from Flavobacterium heparinum: cloning and recombinant expression in Escherichia coli. Biochem Biophys Res Commun (1996) 1.08
Crystal structure of Proteus vulgaris chondroitin sulfate ABC lyase I at 1.9A resolution. J Mol Biol (2003) 1.06
Structural and functional comparison of polysaccharide-degrading enzymes. Crit Rev Biochem Mol Biol (2000) 0.99
Cloning and expression in Escherichia coli of the gene encoding the Proteus vulgaris chondroitin ABC lyase. Appl Microbiol Biotechnol (1994) 0.96
Recombinant expression, purification, and kinetic characterization of chondroitinase AC and chondroitinase B from Flavobacterium heparinum. Biochem Biophys Res Commun (2001) 0.91
Biochemical characterization of the chondroitinase B active site. J Biol Chem (2002) 0.89
On the presence of proteolytic activity in glycosaminoglycan-degrading enzyme preparations. J Histochem Cytochem (1986) 0.83
Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science (2009) 8.61
Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med (2008) 7.05
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature (2005) 4.97
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol (2008) 4.46
Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol (2008) 4.37
Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc Natl Acad Sci U S A (2009) 3.91
Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science (2009) 3.88
Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med (2008) 3.16
Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. Proc Natl Acad Sci U S A (2008) 2.77
Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem Biol (2005) 2.67
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest (2005) 2.38
Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology (2011) 2.28
Frontiers in glycomics: bioinformatics and biomarkers in disease. An NIH white paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11-13, 2006). Proteomics (2008) 2.09
Glycomics: an integrated systems approach to structure-function relationships of glycans. Nat Methods (2005) 2.06
Advancing glycomics: implementation strategies at the consortium for functional glycomics. Glycobiology (2006) 2.05
Extrapolating from sequence--the 2009 H1N1 'swine' influenza virus. Nat Biotechnol (2009) 1.96
Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957. PLoS One (2010) 1.95
Modulating angiogenesis: the yin and the yang in ginseng. Circulation (2004) 1.86
Glycan receptor binding of the influenza A virus H7N9 hemagglutinin. Cell (2013) 1.84
Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci U S A (2012) 1.80
Lung endothelial heparan sulfates mediate cationic peptide-induced barrier dysfunction: a new role for the glycocalyx. Am J Physiol Lung Cell Mol Physiol (2003) 1.76
HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. J Biol Chem (2005) 1.66
Structural determinants for naturally evolving H5N1 hemagglutinin to switch its receptor specificity. Cell (2013) 1.64
Glycomics: a pathway to a class of new and improved therapeutics. Nat Rev Drug Discov (2004) 1.61
Poly(beta-amino ester)s promote cellular uptake of heparin and cancer cell death. Chem Biol (2004) 1.61
Crystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product. J Biol Chem (2006) 1.55
The many faces of the YopM effector from plague causative bacterium Yersinia pestis and its implications for host immune modulation. Innate Immun (2010) 1.53
Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D. J Biol Chem (2002) 1.53
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. Blood (2007) 1.49
Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc Natl Acad Sci U S A (2002) 1.49
Monitoring of heparin and its low-molecular-weight analogs by silicon field effect. Proc Natl Acad Sci U S A (2006) 1.45
A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets. PLoS One (2011) 1.43
Biologically active decorin is a monomer in solution. J Biol Chem (2003) 1.40
Glycans as receptors for influenza pathogenesis. Glycoconj J (2010) 1.38
Orthogonal analytical approaches to detect potential contaminants in heparin. Proc Natl Acad Sci U S A (2009) 1.36
Quantitative description of glycan-receptor binding of influenza A virus H7 hemagglutinin. PLoS One (2013) 1.35
Structural specificity of heparin binding in the fibroblast growth factor family of proteins. Proc Natl Acad Sci U S A (2003) 1.34
Targeting an antimicrobial effector function in insect immunity as a pest control strategy. Proc Natl Acad Sci U S A (2009) 1.32
The impact of heparanese and heparin on cancer metastasis and angiogenesis. Pathophysiol Haemost Thromb (2006) 1.29
Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycans. Semin Thromb Hemost (2002) 1.25
The structure of chondroitin B lyase complexed with glycosaminoglycan oligosaccharides unravels a calcium-dependent catalytic machinery. J Biol Chem (2004) 1.23
Effect of D222G mutation in the hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the 2009 pandemic H1N1 influenza virus. PLoS One (2011) 1.21
Decoding the distribution of glycan receptors for human-adapted influenza A viruses in ferret respiratory tract. PLoS One (2012) 1.21
The heparin/heparan sulfate 2-O-sulfatase from Flavobacterium heparinum. Molecular cloning, recombinant expression, and biochemical characterization. J Biol Chem (2003) 1.20
Determinants of glycan receptor specificity of H2N2 influenza A virus hemagglutinin. PLoS One (2010) 1.20
Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. Arterioscler Thromb Vasc Biol (2003) 1.17
Chinese hamster ovary cells can produce galactose-α-1,3-galactose antigens on proteins. Nat Biotechnol (2010) 1.17
Networks link antigenic and receptor-binding sites of influenza hemagglutinin: mechanistic insight into fitter strain propagation. Sci Rep (2011) 1.14
Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy. Semin Thromb Hemost (2007) 1.08
Structural features of low-molecular-weight heparins affecting their affinity to antithrombin. Thromb Haemost (2009) 1.06
Rational design of low-molecular weight heparins with improved in vivo activity. Proc Natl Acad Sci U S A (2003) 1.04
Profiling the glycoforms of the intact alpha subunit of recombinant human chorionic gonadotropin by high-resolution capillary electrophoresis-mass spectrometry. Anal Chem (2009) 1.01
Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic. Sci Rep (2013) 1.01
Context-specific target definition in influenza a virus hemagglutinin-glycan receptor interactions. Chem Biol (2009) 0.99
Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy. Biochemistry (2008) 0.98
Atomic interaction networks in the core of protein domains and their native folds. PLoS One (2010) 0.98
Renal injury is a consistent finding in Dutch Belted rabbits experimentally infected with enterohemorrhagic Escherichia coli. J Infect Dis (2006) 0.97
Heparanase, heparin and the coagulation system in cancer progression. Thromb Res (2007) 0.95
Biochemical characterization of the chondroitinase ABC I active site. Biochem J (2005) 0.95
Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions. Trends Cardiovasc Med (2002) 0.94
The biosynthesis and catabolism of galactosaminoglycans. Adv Pharmacol (2006) 0.94
Heparin/heparan sulfate N-sulfamidase from Flavobacterium heparinum: structural and biochemical investigation of catalytic nitrogen-sulfur bond cleavage. J Biol Chem (2009) 0.93
Quantification of isomers from a mixture of twelve heparin and heparan sulfate disaccharides using tandem mass spectrometry. Rapid Commun Mass Spectrom (2005) 0.92
Targeting of mitogen-activated protein kinases and phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced angiogenesis. Circulation (2003) 0.91
Heparin/heparan sulfate 6-O-sulfatase from Flavobacterium heparinum: integrated structural and biochemical investigation of enzyme active site and substrate specificity. J Biol Chem (2009) 0.90
Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation. FASEB J (2003) 0.90
Harnessing glycomics technologies: integrating structure with function for glycan characterization. Electrophoresis (2012) 0.89
Biochemical characterization of the chondroitinase B active site. J Biol Chem (2002) 0.89
Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route. Proc Natl Acad Sci U S A (2004) 0.89
N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses. J Virol (2013) 0.88
The heparin/heparan sulfate 2-O-sulfatase from Flavobacterium heparinum. A structural and biochemical study of the enzyme active site and saccharide substrate specificity. J Biol Chem (2003) 0.88
The catalytic machinery of chondroitinase ABC I utilizes a calcium coordination strategy to optimally process dermatan sulfate. Biochemistry (2006) 0.88
Quantitative characterization of glycan-receptor binding of H9N2 influenza A virus hemagglutinin. PLoS One (2013) 0.88
Glycomics-based analysis of chicken red blood cells provides insight into the selectivity of the viral agglutination assay. FEBS J (2011) 0.87
Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency. Proc Natl Acad Sci U S A (2013) 0.86
Unlocking the secrets of syndecans: transgenic organisms as a potential key. Glycoconj J (2003) 0.86
Dimeric fibroblast growth factor-2 enhances functional recovery after focal cerebral ischemia. Restor Neurol Neurosci (2005) 0.86
Modulation of gamma-secretase for the treatment of Alzheimer's disease. Int J Alzheimers Dis (2012) 0.86
Assessment of the quality and structural integrity of a complex glycoprotein mixture following extraction from the formulated biopharmaceutical drug product. J Pharm Biomed Anal (2010) 0.86
Heparin and heparan sulfate: analyzing structure and microheterogeneity. Handb Exp Pharmacol (2012) 0.86
A novel computational approach to integrate NMR spectroscopy and capillary electrophoresis for structure assignment of heparin and heparan sulfate oligosaccharides. Glycobiology (2002) 0.85
Cooperativity in glycan-protein interactions. Chem Biol (2007) 0.85
The sweet side of biomarker discovery. Nat Biotechnol (2006) 0.84
Expression in Escherichia coli, purification and kinetic characterization of human heparan sulfate 3-O-sulfotransferase-1. Biochem Biophys Res Commun (2002) 0.84
Receptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferrets. Virology (2013) 0.83